1 | after | 227,171 |
2 | during/after | 17 |
3 | imbibitional | 4 |
4 | postaortic | 4 |
5 | overstitch | 3 |
6 | post-ezetimibe | 3 |
7 | post-tulathromycin | 3 |
8 | withstands | 3 |
9 | noncanulated | 2 |
10 | post-intravenous | 2 |
11 | post-snf | 2 |
12 | post-vaginal | 2 |
13 | sessions.the | 2 |
14 | 0/day | 1 |
15 | 384/year | 1 |
16 | aafter | 1 |
17 | after/following | 1 |
18 | alpha-pregnan-20 | 1 |
19 | c6,7 | 1 |
20 | d-ribofuranosylbenzimidazole | 1 |
21 | füth-mayo | 1 |
22 | later.the | 1 |
23 | n-availability | 1 |
24 | nanobeads | 1 |
25 | non-interrelated | 1 |
26 | post-a-ct. | 1 |
27 | post-carcinogen | 1 |
28 | post-detomidine | 1 |
29 | post-dose1 | 1 |
30 | post-dose2 | 1 |
31 | post-hts | 1 |
32 | post-infrainguinal | 1 |
33 | post-left | 1 |
34 | post-mild | 1 |
35 | post-parenteral | 1 |
36 | post-remifentanil | 1 |
37 | post-rt-cgm | 1 |
38 | post-substance | 1 |
39 | post-tracer | 1 |
40 | post-valve | 1 |
41 | postbeverage | 1 |
42 | postcarbohydrate | 1 |
43 | postinfrarenal | 1 |
44 | postintraperitoneal | 1 |
45 | postintravascular | 1 |
46 | postobserved | 1 |
47 | postoperatively.for | 1 |
48 | postsephadex | 1 |
49 | postsurgery20at | 1 |
50 | postthoracoabdominal | 1 |
51 | postvoice | 1 |
52 | power.stratified | 1 |
53 | prepercutaneous | 1 |
54 | rapidly.the | 1 |
55 | sham-not/placebo | 1 |
56 | survival.for | 1 |
57 | three-a-side | 1 |
58 | training-sessions | 1 |
59 | uder | 1 |
60 | αfor | 1 |
1 | 0/day | 1 |
2 | 384/year | 1 |
3 | aafter | 1 |
4 | after | 227,171 |
5 | after/following | 1 |
6 | alpha-pregnan-20 | 1 |
7 | c6,7 | 1 |
8 | d-ribofuranosylbenzimidazole | 1 |
9 | during/after | 17 |
10 | füth-mayo | 1 |
11 | imbibitional | 4 |
12 | later.the | 1 |
13 | n-availability | 1 |
14 | nanobeads | 1 |
15 | non-interrelated | 1 |
16 | noncanulated | 2 |
17 | overstitch | 3 |
18 | post-a-ct. | 1 |
19 | post-carcinogen | 1 |
20 | post-detomidine | 1 |
21 | post-dose1 | 1 |
22 | post-dose2 | 1 |
23 | post-ezetimibe | 3 |
24 | post-hts | 1 |
25 | post-infrainguinal | 1 |
26 | post-intravenous | 2 |
27 | post-left | 1 |
28 | post-mild | 1 |
29 | post-parenteral | 1 |
30 | post-remifentanil | 1 |
31 | post-rt-cgm | 1 |
32 | post-snf | 2 |
33 | post-substance | 1 |
34 | post-tracer | 1 |
35 | post-tulathromycin | 3 |
36 | post-vaginal | 2 |
37 | post-valve | 1 |
38 | postaortic | 4 |
39 | postbeverage | 1 |
40 | postcarbohydrate | 1 |
41 | postinfrarenal | 1 |
42 | postintraperitoneal | 1 |
43 | postintravascular | 1 |
44 | postobserved | 1 |
45 | postoperatively.for | 1 |
46 | postsephadex | 1 |
47 | postsurgery20at | 1 |
48 | postthoracoabdominal | 1 |
49 | postvoice | 1 |
50 | power.stratified | 1 |
51 | prepercutaneous | 1 |
52 | rapidly.the | 1 |
53 | sessions.the | 2 |
54 | sham-not/placebo | 1 |
55 | survival.for | 1 |
56 | three-a-side | 1 |
57 | training-sessions | 1 |
58 | uder | 1 |
59 | withstands | 3 |
60 | αfor | 1 |
1 | post-a-ct. | 1 |
2 | alpha-pregnan-20 | 1 |
3 | post-dose1 | 1 |
4 | post-dose2 | 1 |
5 | c6,7 | 1 |
6 | postaortic | 4 |
7 | power.stratified | 1 |
8 | non-interrelated | 1 |
9 | noncanulated | 2 |
10 | postobserved | 1 |
11 | post-mild | 1 |
12 | post-ezetimibe | 3 |
13 | postvoice | 1 |
14 | post-substance | 1 |
15 | three-a-side | 1 |
16 | postbeverage | 1 |
17 | later.the | 1 |
18 | sessions.the | 2 |
19 | rapidly.the | 1 |
20 | d-ribofuranosylbenzimidazole | 1 |
21 | post-detomidine | 1 |
22 | postcarbohydrate | 1 |
23 | post-valve | 1 |
24 | post-snf | 2 |
25 | after/following | 1 |
26 | overstitch | 3 |
27 | postintraperitoneal | 1 |
28 | postinfrarenal | 1 |
29 | post-vaginal | 2 |
30 | postthoracoabdominal | 1 |
31 | post-infrainguinal | 1 |
32 | imbibitional | 4 |
33 | post-parenteral | 1 |
34 | post-remifentanil | 1 |
35 | post-rt-cgm | 1 |
36 | post-carcinogen | 1 |
37 | post-tulathromycin | 3 |
38 | sham-not/placebo | 1 |
39 | füth-mayo | 1 |
40 | 384/year | 1 |
41 | postintravascular | 1 |
42 | post-tracer | 1 |
43 | uder | 1 |
44 | after | 227,171 |
45 | during/after | 17 |
46 | aafter | 1 |
47 | survival.for | 1 |
48 | postoperatively.for | 1 |
49 | αfor | 1 |
50 | nanobeads | 1 |
51 | withstands | 3 |
52 | training-sessions | 1 |
53 | post-hts | 1 |
54 | prepercutaneous | 1 |
55 | post-intravenous | 2 |
56 | postsurgery20at | 1 |
57 | post-left | 1 |
58 | postsephadex | 1 |
59 | 0/day | 1 |
60 | n-availability | 1 |